Perda do sítio de restriçäo fok-I no codon 918 do proto-oncogenese RET na neoplasia endócrina múltipla tipo 2B

Toledo, Sérgio P. A; Ezabella, Marilza C. L; Abelin, Neusa; Hayashida, César Y; Dahia, Patrícia L. M.
Arq. bras. endocrinol. metab ; 41(1): 14-7, mar. 1997. ilus
Artículo en Portugués | LILACS | ID: lil-262187

Documentos relacionados

  1. A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.
  2. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
  3. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.
  4. A novel deletion in the RET proto-oncogene found in sporadic medullary thyroid carcinoma.
  5. Mechanisms of the role of proto-oncogene activation in promoting malignant transformation of mature B cells.
  6. RET gene and its implications for cancer.
  7. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
  8. Characterization of wild-type and mutated RET proto- oncogene associated with familial medullary thyroid cancer.
  9. A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma.
  10. Hereditary medullary thyroid carcinoma in patients greater than 50 years old.